Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of INFLAmmasome NLRP3 and PLAtelets Functions During Severe COVID-19 Infection

NCT04397822 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT04397822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of INFLAmmasome NLRP3 and PLAtelets Functions During Severe COVID-19 Infection
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Completed
Start date
April 16, 2020
Completion date
May 25, 2022
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19